KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $27.3 billion.

  • Novartis Ag's Total Current Liabilities fell 492.82% to $27.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $27.3 billion, marking a year-over-year decrease of 492.82%. This contributed to the annual value of $27.3 billion for FY2025, which is 492.82% down from last year.
  • Latest data reveals that Novartis Ag reported Total Current Liabilities of $27.3 billion as of Q4 2025, which was down 492.82% from $32.0 billion recorded in Q3 2025.
  • Novartis Ag's Total Current Liabilities' 5-year high stood at $48.4 billion during Q3 2023, with a 5-year trough of $26.4 billion in Q4 2023.
  • For the 5-year period, Novartis Ag's Total Current Liabilities averaged around $30.4 billion, with its median value being $29.7 billion (2021).
  • Per our database at Business Quant, Novartis Ag's Total Current Liabilities soared by 7185.01% in 2023 and then tumbled by 4186.76% in 2024.
  • Over the past 5 years, Novartis Ag's Total Current Liabilities (Quarter) stood at $30.2 billion in 2021, then decreased by 5.14% to $28.7 billion in 2022, then decreased by 7.91% to $26.4 billion in 2023, then increased by 8.72% to $28.7 billion in 2024, then decreased by 4.93% to $27.3 billion in 2025.
  • Its last three reported values are $27.3 billion in Q4 2025, $32.0 billion for Q3 2025, and $31.7 billion during Q2 2025.